Your browser doesn't support javascript.
loading
Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel).
Mueller, Ruediger B; Schulze-Koops, Hendrik; Furst, Daniel E; Cohen, Stanley B; Kwok, Kenneth; Wang, Lisy; Killeen, Tim; von Kempis, Johannes.
Afiliação
  • Mueller RB; Rheumazentrum Ostschweiz, St. Jakobsstr. 20, 9000, St. Gallen, Switzerland. ruediger.mueller@hin.ch.
  • Schulze-Koops H; Division of Rheumatology and Immunology, Kantonsspital St. Gallen, St. Gallen, Switzerland. ruediger.mueller@hin.ch.
  • Furst DE; Division of Rheumatology and Clinical Immunology, Department of Internal Medicine IV, Ludwig-Maximilians-University Munich, Munich, Germany. ruediger.mueller@hin.ch.
  • Cohen SB; Division of Rheumatology and Clinical Immunology, Department of Internal Medicine IV, Ludwig-Maximilians-University Munich, Munich, Germany.
  • Kwok K; UCLA, Los Angeles, CA, USA.
  • Wang L; University of Washington, Seattle, WA, USA.
  • Killeen T; University of Florence, Florence, Italy.
  • von Kempis J; Metroplex Clinical Research Center and University of Texas Southwestern Medical Center, Dallas, TX, USA.
Clin Rheumatol ; 41(4): 1045-1055, 2022 Apr.
Article em En | MEDLINE | ID: mdl-34973077

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperidinas / Artrite Reumatoide / Pirimidinas / Antirreumáticos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperidinas / Artrite Reumatoide / Pirimidinas / Antirreumáticos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article